Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the management team will be presenting at several upcoming conferences. The presentation details are as follows:
- Fierce Biotech Webinar on Tuesday, October 30, 2012, at 11:00 am ET Title: Personalized Medicine in Oncology Summary: Learn how sequencing, genotyping and informatics systems are changing the way cancer drugs are developed. Their use for patient selection during clinical trials, implementation of adaptive trial designs and increasing the speed of programs through the clinic will be discussed. Webcast Registration: http://bit.ly/XK6ZuQ
- New York CEO Conference on November 1-2, 2012, at the Apella Hotel in New York City, NY
- Lazard Capital Markers Healthcare Conference on Tuesday, November 13, 2012, at 8:30 am ET at the Pierre Hotel in New York City, NY. A webcast of the presentation can be accessed by visiting the investors section of the Company’s website at www.verastem.com. A replay of the webcast will be archived on the Verastem website for two weeks following the presentation date.